IRulya Therapeutics Inc. (IRLA)
NASDAQ: IRLA · Real-Time Price · USD
32.95
+1.33 (4.21%)
At close: Oct 30, 2026, 4:00 PM EDT
33.50
+0.55 (1.67%)
After-hours: Oct 30, 2026, 7:30 PM EDT
IRulya Therapeutics Employees
IRulya Therapeutics had 38 employees as of December 31, 2025. The number of employees increased by 2 or 5.56% compared to the previous year. That makes IRulya Therapeutics the 36,256th largest employer in the world and 4,959th in the United States.
Employees
38
Change (1Y)
2
Growth (1Y)
5.56%
Revenue / Employee
n/a
Profits / Employee
-$2,433,579
Market Cap
33.51M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 38 | 2 | 5.56% | 38 | 0 |
| Dec 31, 2024 | 36 | 4 | 12.50% | 36 | 0 |
| Dec 31, 2023 | 32 | 11 | 52.38% | 32 | 0 |
| Dec 31, 2022 | 21 | -34 | -61.82% | 21 | 0 |
| Dec 31, 2021 | 55 | 17 | 44.74% | 55 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| EyePoint | 214 |
| Metagenomi Therapeutics | 113 |
| Aligos Therapeutics | 82 |
| NextCure | 40 |
| Aardvark Therapeutics | 28 |
| Filana Therapeutics | 20 |
| BriaCell Therapeutics | 16 |
| TransCode Therapeutics | 12 |
IRLA News
- 17 days ago - IRulya Therapeutics to Participate in the Craig-Hallum Biotech Catalyst Conference - GlobeNewsWire
- 23 days ago - Quince Therapeutics Relaunches as IRulya Therapeutics with a Focus on the Clinical Development of LAM-001, Targeting a Key Pathway in Pulmonary Disease - GlobeNewsWire
- 23 days ago - IRulya Therapeutics Slides: Corporate presentation - Filings
- 26 days ago - IRulya Therapeutics Transcript: EGM 2026 - Transcripts
- 4 weeks ago - IRulya Therapeutics Proxy statement: Proxy filing - Filings
- 4 weeks ago - IRulya Therapeutics Transcript: KOL event - Transcripts
- 4 weeks ago - IRulya Therapeutics Press release: KOL event - Filings
- 6 weeks ago - Quince Therapeutics to Host Virtual KOL Event to Discuss the Current Treatment Landscape for PH-ILD and BOS and the Role for LAM-001 as a Potential Therapeutic Option on September 28, 2026 - GlobeNewsWire